’60 Minutes’ examines ‘astronomical cost’ of several cancer drugs The CBS news magazine aired a segment Sunday that looked into why the medications cost so very much and whether they're more effective than less-expensive alternatives really. CBS '60 Minutes': The Cost Of Cancer Drugs Cancer is so pervasive that it touches just about any grouped family members in this country. Several out of three People in america will be identified as having some type of it in their lifetime. And mainly because anyone who's experienced it has learned, the shock and stress of the analysis is followed by another jolt: the high cost of cancer medications.The trial was prepared to keep as a phase 3 study if a lot more than 11 responses were seen in the first 40 patients who were randomly designated to the FOLFIRINOX group. Patients from the phase 2 analysis were contained in the phase 3 analysis. The primary end stage for the phase 3 analysis was general survival. Secondary end points were progression-free survival, tumor response, safety, and standard of living. The statistical factors are detailed in the Sample Size Dedication section in the Supplementary Appendix. All analyses were performed upon an intention-to-deal with basis. Qualitative variables were compared with the use of the chi-square check or Fisher’s check, quantitative variables with the use of Student’s t-check or a nonparametric test, and survival data with the use of a stratified log-rank check.